RIVAROXABAN S.K. 10 MG

Nazione: Israele

Lingua: inglese

Fonte: Ministry of Health

Principio attivo:

RIVAROXABAN

Commercializzato da:

K.S.KIM INTERNATIONAL (SK- PHARMA) LTD., ISRAEL

Codice ATC:

B01AF01

Forma farmaceutica:

FILM COATED TABLETS

Composizione:

RIVAROXABAN 10 MG

Via di somministrazione:

PER OS

Tipo di ricetta:

Required

Prodotto da:

PHAROS – PHARMACEUTICAL ORIENTED SERVICES SINGLE MEMBER LTD, GREECE

Area terapeutica:

RIVAROXABAN

Indicazioni terapeutiche:

Prevention of venous thromboembolism (VTE) in adult patients undergoing elective hip or knee replacement surgery. Prevention of recurrent deep vein thrombosis (DVT) and pulmonary embolism (PE), in adults (following completion of at least 6 months therapy for DVT or PE).

Data dell'autorizzazione:

2022-08-17

Foglio illustrativo

RIVAROXABAN S.K. 10mg
RIVAROXABAN S.K. 15mg
RIVAROXABAN S.K. 20mg
SAFETY INFORMATION CARD FOR PATIENTS
UNDER ANTICOAGULANT TREATMENT
WITH RIVAROXABAN S.K.
Keep this card with you at all times
Present this card to every doctor
or dentist at the beginning of the visit
The patient carrying this card is under
anticoagulation treatment with RIVAROXABAN S.K
Name
Address
Date of birth
Weight
Information regarding concomitant medications and
diseases
Information in case of emergency
In case of emergency, please notify:
Doctor’s name
Doctor’s phone
Please also notify:
Name
Relationship
Phone
Emergency phone (Clinic/first aid)
Information regarding use of the medicine
Treatment start date
Indication
Dosage and administration regimen
Renal function at treatment onset
(creatinine clearance mL/min)
Information for healthcare providers:
INR values should not be used as they are not a
dependable measure of the anticoagulant activity of
RIVAROXABAN S.K
Information on anticoagulants and guidance
for the patient
RIVAROXABAN S.K thins the blood, which prevents you
from getting dangerous blood clots.
RIVAROXABAN S.K must be taken exactly as prescribed by
your doctor. To ensure optimal protection from blood clots
you should strictly comply with the administration
schedule as recommended by your doctor and never skip
a dose, unless instructed by the doctor.
You must not stop taking RIVAROXABAN S.K without first
talking to your doctor as your risk of blood clots may
increase.
Administration with food:
To ensure optimal treatment effectiveness:
RIVAROXABAN S.K 20 mg must be taken with food.
RIVAROXABAN S.K 15 mg must be taken with food.
RIVAROXABAN S.K 10 mg can be taken with or without
food.
The tablet should be swallowed with water. If you have
difficulty swallowing the tablet whole, the tablet can be
crushed and mixed with water or apple puree immediately
before administration. For RIVAROXABAN S.K 15 mg and 20
mg, the crushed medicine should then be immediately
followed by food.
If you forgot to take RIVAROXABAN S.K at the requi